This 2016 review article provides a comprehensive overview of antisynthetase syndrome (ASS), an autoimmune condition characterized by the presence of anti-aminoacyl tRNA synthetase antibodies, most commonly anti-Jo-1. Clinical manifestations include interstitial lung disease (ILD), myositis, arthritis, Raynaud’s phenomenon, and “mechanic’s hands.” ILD is notably more prevalent and severe in ASS
This 2023 expert consensus outlines best practices for utilizing anti-double-stranded DNA (anti-dsDNA) autoantibodies in diagnosing and monitoring systemic lupus erythematosus (SLE). While anti-dsDNA antibodies are integral to SLE classification and disease activity assessment, their clinical utility is hindered by assay heterogeneity, lack of standardization, and variable specificity across populations. The
This 2010 guideline by the European Federation of Neurological Societies (EFNS) offers evidence-based recommendations for diagnosing and managing European Lyme neuroborreliosis (LNB). It emphasizes clinical assessment supported by cerebrospinal fluid (CSF) analysis, including pleocytosis and intrathecal Borrelia-specific antibody production. The guidelines recommend intravenous ceftriaxone (2 g/day for 14 days) as
This 2021 comprehensive review article provides an in-depth analysis of Lyme disease, a tick-borne illness caused by Borrelia burgdorferi sensu lato complex. The disease is prevalent across the Northern Hemisphere and is transmitted by ticks from the Ixodes ricinus complex. The article discusses the increasing global incidence of Lyme disease,
This 2016 review provides an evidence-based framework for diagnosing and managing Small Intestinal Bacterial Overgrowth (SIBO). Diagnosis methods include glucose and lactulose breath tests, as well as small intestinal aspiration and culture, though standardization issues exist. Treatment typically involves a two-week course of broad-spectrum antibiotics such as rifaximin, amoxicillin, or
This 2018 review examines Small Intestinal Bacterial Overgrowth (SIBO), a condition characterized by excessive bacteria in the small intestine, leading to symptoms like bloating, diarrhea, and malabsorption. The article discusses the challenges in diagnosing SIBO due to the lack of a gold standard, with current methods including breath tests and
These guidelines, developed by the British Society of Gastroenterology, provide comprehensive recommendations for the diagnosis and management of iron deficiency anemia (IDA) in adults. Key points include the importance of confirming IDA with appropriate laboratory tests (e.g., serum ferritin), investigating underlying causes such as gastrointestinal bleeding, and initiating treatment with
This comprehensive review outlines the diagnosis and management strategies for Pneumocystis jirovecii pneumonia (PJP), a life-threatening opportunistic fungal infection predominantly affecting immunocompromised individuals. The article emphasizes the importance of early recognition, especially in patients with HIV/AIDS, organ transplants, or those undergoing immunosuppressive therapy. Diagnostic approaches include imaging techniques like chest
This 2022 comprehensive review discusses the genetic factors, diagnostic methods, current treatments, and emerging alternative therapies for prostate cancer. It highlights the role of genetic mutations in disease onset and progression, standard diagnostic tools like PSA testing and biopsies, and conventional treatments including surgery, radiotherapy, and hormone therapy. The review
This guideline provides comprehensive recommendations for diagnosing and managing adult growth hormone deficiency (GHD). It emphasizes that GHD can be congenital or acquired, often due to pituitary or hypothalamic lesions. Diagnosis typically requires stimulation testing, as random GH and IGF-1 levels are insufficient. GH replacement therapy is indicated for adults
